Skip to main content
Caplight Logo









Genisphere

Genisphere

Private
Hatfield, PennsylvaniaEnterprise Softwarehttps://wawamenus.com/wawa-store-locator/

Last Round

Early Funding

Nov 1, 2017

Total Funding Raised

$7M

Company Overview

Genisphere operates in Enterprise Software and is based in Hatfield, Pennsylvania. Its latest recorded funding round was an Early Funding round in November 2017.

Genisphere is a drug delivery company that has developed a DNA-based nanotechnology platform for targeted drug delivery.

Sector

Enterprise Software

Verticals

Vertical SaaS, Retail Technology

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Genisphere Comparables

Compare Genisphere with similar companies based on industry and business-model similarity.

Genisphere comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Menujo
91%
FineDine
86%
TableQR
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Genisphere Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingNov 1, 2017
VC RoundOct 1, 2015
VC RoundSep 16, 2014
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Genisphere Investors

Notable investors and investment history

Genisphere investors
InvestorRounds
Corporate Fuel AdvisorsVC Round
Lankenau Institute for Medical ResearchVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2017

    Raised $7M in early funding.

  • Oct 1, 2015

    $4M round including Lankenau Institute for Medical Research

Book a demo to see all signals

For institutional investors. Book with your work email.

Genisphere Filings

Explore SEC and related filing metadata, where available.

Genisphere filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Genisphere's valuation, stock price, and market status.

Is Genisphere a public or private company?

Genisphere is a private company.

What is the current stock price of Genisphere?

Genisphere is a private company, so its shares have no public market price. Caplight tracks Genisphere's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Genisphere worth (valuation)?

Valuation information for Genisphere is not publicly available.

Can I buy Genisphere stock?

Genisphere shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Genisphere's last funding round?

Genisphere's most recent funding round was Early Funding on November 1, 2017.

Who are the main investors in Genisphere?

Key investors in Genisphere include Corporate Fuel Advisors, Lankenau Institute for Medical Research.

Will Genisphere IPO soon?

No public IPO plans have been announced for Genisphere.

How can I track Genisphere secondary market activity?

Caplight tracks bids, offers, and trades in Genisphere's shares on secondary markets.

Firmographic Details

HeadquartersHatfield, Pennsylvania
Year Founded1997
Last FundingNov 1, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?